Baebies

Durham, United States Founded: 2013 • Age: 13 yrs
Provider of diagnostic products for pediatrics

About Baebies

Baebies is a company based in Durham (United States) founded in 2013 by Richard West and Vamsee Pamula. Baebies has raised $95.89 million across 29 funding rounds from investors including Duke University, HHS and CARB-X. Baebies offers products and services including FINDER Platform and G6PD Test. Baebies operates in a competitive market with competitors including Vgenomics and DNADVENTLifesciences, among others.

Operational Areas
Key Metrics
  • Annual Revenue
    ₹1.42 Cr

    FY 2025 · -11% YoY

  • Net Profit
    ₹0.17 Cr

    FY 2025 · 12% margin

  • EBITDA
    ₹0.28 Cr

    FY 2025 · 20% margin

  • Total Equity Funding
    $95.89M (USD)

    in 29 rounds

  • Latest Funding Round
    $2.05M (USD), Series C

    Sep 2025

  • Investors

Products & Services of Baebies

Baebies offers a comprehensive portfolio of products and services, including FINDER Platform and G6PD Test.

FINDER Platform
Diagnostic Platform

Multifunctional system for rapid medical tests using digital microfluidics.

G6PD Test
Diagnostic Test

Assesses G6PD deficiency for clinical interventions on the platform.

Apps and channels of Baebies

its YouTube channel Baebies, Inc. has 277 subscribers and 21 videos.

Baebies, Inc.
YouTube 277 subscribers 21 videos Science & Technology
Open channel

Videos from Baebies

The most watched videos on Baebies's YouTube channel, Baebies, Inc. (277 subscribers). Click a video to play it here.

Digital Microfluidics - Electrowetting Droplet Operations (accelerated)
18.1K views
Baebies FINDER | RT-PCR Cartridge Protocol
7.2K views
Baebies FINDER | Cartridge Protocol | Near-patient Testing Platform
7K views
Rapid RT-PCR Testing with Digital Microfluidics | Baebies Webinar
6.3K views

More on Baebies, Inc..

Funding Insights of Baebies

Baebies has successfully raised a total of $95.89M across 29 strategic funding rounds. The most recent funding activity was a Series C round of $2.05 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $95.89M
  • Total Rounds 29
  • Last Round Series C β€” $2.05M
  • First Round $3.8M

    (Sep 2013)

  • Investors Count 9

Latest 10 of 29 funding rounds of Baebies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2025$2.05MSeries C––
–
Apr 2023$1.3MGrant––
May 2022$2.04MGrant––
May 2022$37.57MSeries C––
–
Feb 2022$11.9MDebt – Conventional––
–
Apr 2021–Grant––
Feb 2021$1.53MGrant––
Sep 2020$1.53MGrant––
Sep 2019$1.51MGrant––
Sep 2019$1.6MGrant––
Valuation history

9 investors in total: 9 institutional.

Investors in Baebies

Baebies has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Duke University, HHS and CARB-X.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
-
–dukeangelnetwork.duke.edu-
Angel investments are made in Charleston-based companies by member network.
2004chapsc.comCharleston, United States
-
–rexhealthventures.com-
Biotech startups are incubated and funded in North Carolina.
1984ncbiotech.orgDurham, United States
Public health and human services are overseen by HHS.
1953hhs.gov-
Antibiotics, vaccines, and diagnostics against drug-resistant bacteria are developed.
2016carb-x.orgBoston, United States
Manufacturer of diversified displays
1993boe.comBeijing, China
Multiple courses and degrees across diversified streams are offered.
1838duke.eduUnited States
-
–cunningcapital.tcc.mode-
Premium access

Investor details for Baebies

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Baebies Diagnostics India Private Limited (Baebies)

Baebies Diagnostics India Private Limited is the primary company behind Baebies. The board of Baebies Diagnostics India Private Limited currently have 2 directors; the longest-serving is Ramakrishna Sarma Sista, appointed in 2023.

DirectorDesignationAppointedTenureEntity
Ramakrishna Sarma Sista
DIN 09862251
Director18 Jan 20233 yrs 8 moBaebies Diagnostics India Private Limited
Vamsee Krishna Pamula
DIN 09862250
Director18 Jan 20233 yrs 8 moBaebies Diagnostics India Private Limited

People of Baebies

12 people are tracked at Baebies (7 in leadership, 2 in board & advisors, 3 in team).

NameRoleGroup
Richard West
Co-Founder & CEOLeadership
Co-Founder & PresidentLeadership
Jennifer Elderbroom
Associate Director of Product DevelopmentLeadership
Cadwell, Charles
Vice President-FinanceLeadership
Thomas L. Carter
Vice President of OperationsLeadership
Vijay Srinivasan
VP, Product DevelopmentLeadership
Susan Wilhelm
Director, Grants And ContractsLeadership
Nicholas Naclerio
Board MemberBoard & advisors
William A. Hawkins
Board MemberBoard & advisors
Devika Varma, Ph.D.
Senior ScientistTeam
Anita Vaidya
Scientist IITeam
Virginia Thompson
Senior Office And Payroll ManagerTeam
Premium access

Complete people profiles for Baebies

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Baebies

Figures of Baebies Diagnostics India Private Limited, the primary company behind Baebies, for FY 2025. Revenue was ₹1.42 Cr (-11% year on year). Net profit was ₹0.17 Cr (12% margin). EBITDA was ₹0.28 Cr (20% margin).

  • ₹1.42 CrRevenue · FY 2025 · -11% YoY
  • ₹0.17 CrNet profit · 12% margin
  • ₹0.28 CrEBITDA · 20% margin
  • ₹0.01 CrPaid-up capital
  • 6Employees (provident fund records)

Balance sheet, profit and loss, cash flow and ratios of Baebies Diagnostics India Private Limited are on its company page.

Premium access

Detailed financial statements for Baebies

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Baebies

3 dated milestones of Baebies across 12 years, from founding to its latest funding, stage changes and deals.

  1. Founded Baebies is founded.
  2. Funding First funding round of $3.8M.
  3. Funding Latest funding round, Series C, of $2.0M.

Competitors of Baebies

Baebies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vgenomics and DNADVENTLifesciences, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
vgenomics.in2021Noida, India––
Diagnostic and therapeutic solutions for inborn diseases are developed.
dnadvent.com2016Hyderabad, India––
Offers comprehensive genomic-based diagnostic tests for newborn babies.
Premium access

Detailed competitors of Baebies

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Baebies

The website of Baebies (baebies.com) receives about 3.2K visits a month and ranks #4,887,904 among all websites worldwide, #5,717 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    3.2K

    ▼ 3.7% vs previous month

  • Unique visitors
    1.5K

    per month

  • Global rank
    #4,887,904

    among all websites

  • Category rank
    #5,717

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Baebies. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
savebabies.org
100%
–#6,647,685View details

Latest news on Baebies

Premium access

Complete news archive for Baebies

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Baebies

10 companies that operate in the same segment as Baebies (Pediatrics), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Owlet is recognized for developing FDA-cleared smart baby monitors.
2013Lehi, Utah, United StatesUSD 54.96 MUSD 105.71 M85
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
1998Cambridge, Massachusetts, United StatesUSD 206.25 MUSD 296.15 M253
Smart baby monitors and sleep tracking solutions are provided.
2014New York, New York, United StatesUSD 116.6 M––
Eye-tracking solutions for vision assessment and treatment are provided.
2016Lod, Central District, IsraelUSD 8 M––
Patient vital signs are monitored via wearable devices and software.
2018Niles, Illinois, United StatesUSD 71 M––
Pediatric orthopedic devices are developed for surgical applications.
2006Warsaw, United StatesUSD 51.55 MUSD 236.35 M562
Gene therapy platform for rare disease treatments is developed.
2018Exton, Pennsylvania, United StatesUSD 192.8 M–41
Pediatric cardiac surgical devices are developed for congenital heart defects.
2011Pittsburgh, Pennsylvania, United StatesUSD 22.56 M––
Drug-delivery platforms for pediatric wart treatments are developed.
2020San Antonio, Texas, United StatesUSD 262.71 M––
Online genetic engineering tools for drug development are provided.
2020Philadelphia, Pennsylvania, United StatesUSD 115 M–7
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Baebies

Baebies was founded in 2013.

Baebies is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.

Richard West is the current CEO of Baebies. They have also founded this company.

Baebies is a funded company, having raised a total of $95.89M across 29 funding rounds to date. The company's 1st funding round was a Grant of $1.6M, raised on Sep 2013.

The primary company behind Baebies, Baebies Diagnostics India Private Limited, reported revenue of β‚Ή1.42 Cr for FY 2025, down 11% year on year.

Provider of diagnostic products for pediatrics. Its proprietary platform the SEEKER is a microfluidic instrument that enables the high-throughput measurement of enzymatic activity in dried blood specimens of newborn babies. It also has another product the FINDER which is an automated screening solution for critical pediatric tests.

Baebies's top competitors include Vgenomics and DNADVENTLifesciences.

Baebies offers FINDER Platform and G6PD Test.

Baebies has 9 investors. Key investors include Duke University, HHS, CARB-X, BOE Technology Group, and NCBiotech.

Baebies operates through Baebies Diagnostics India Private Limited.

The legal entities of Baebies currently have 2 directors, including Ramakrishna Sarma Sista, Vamsee Krishna Pamula.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available